Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
149.56%
↑ 111% above average
Average (28q)
-1332.22%
Historical baseline
Range
High:222.16%
Low:-38623.88%
Volatility
-2915.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 149.56% |
| Q2 2025 | 60.07% |
| Q1 2025 | 38.31% |
| Q4 2024 | -67.12% |
| Q3 2024 | 42.22% |
| Q2 2024 | 2.54% |
| Q1 2024 | 29.11% |
| Q4 2023 | -51.17% |
| Q3 2023 | 68.14% |
| Q2 2023 | -145.73% |
| Q1 2023 | 17.30% |
| Q4 2022 | -2.03% |
| Q3 2022 | -32.63% |
| Q2 2022 | 26.45% |
| Q1 2022 | -163.61% |
| Q4 2021 | 222.16% |
| Q3 2021 | -7.32% |
| Q2 2021 | 13.14% |
| Q1 2021 | -35.83% |
| Q4 2020 | -72.99% |
| Q3 2020 | 7.51% |
| Q2 2020 | -9.11% |
| Q1 2020 | -18.71% |
| Q4 2019 | -18.99% |
| Q3 2019 | -11.29% |
| Q2 2019 | -127.58% |
| Q1 2019 | 77.04% |
| Q4 2018 | -38623.88% |
| Q3 2018 | 0.00% |